A
Adaptimmune - ADR (ADAP)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Adaptimmune - ADR (ADAP)
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more
- USD0.27
- USD0.28
- USD0.26
- USD1.48
- -1.30%
- 141M
- 563.62k
- 618.19k
- 71M
- 0.20
- -78.30%
Stock News
2 hours ago
The Best Nuclear Stock to Invest $1,000 in Right Now
Yahoo
yesterday
Deal-making across Wall Street is ramping up, Jim Cramer says
CNBC
yesterday
Robinhood misses out on the S&P 500 yet again, with Trade Desk to soon join the index
MarketWatch
yesterday
San Francisco rolls out Microsoft's Copilot AI for 30,000 city workers
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
